Background: Detection of recurrent/persistent thyroid cancer has improved significantly in
the past decade. Disease is detected earlier in recently treated patients and localized in …

Recurrence of papillary thyroid cancer (PTC) after optimized surgery requires a full
understanding of the disease, especially as it has changed in the last 15 years, what …

The natural history of papillary thyroid cancer (PTC) is such that many patients reach normal
life expectancy after total thyroidectomy and radioiodine therapy (1). Still, a large number of …

Context: Although commonly performed, data are lacking regarding efficacy and safety of
lymph node dissection (LND) for recurrent/persistent papillary thyroid cancer (PTC) …

Objective To define a rational, cost-effective, simple approach to managing most patients
with papillary thyroid cancer (PTC) who are at low-risk of either cause-specific mortality or …

Background Achieving an undetectable serum thyroglobulin (Tg) level (< 1.0 ng/mL) after
surgical and radioiodine treatment for papillary thyroid cancer (PTC) is associated with low …

Objective: Prophylactic neck dissection for small papillary carcinoma remains controversial.
Radioiodine ablation is not recommended for tumors less than 10 mm and depends on …

Objective: The objective of the study was to determine the outcome of surgical resection of
metastatic papillary thyroid cancer (PTC) in cervical lymph nodes after failure of initial …

Background Prophylactic central lymph node dissection (CLND) in papillary thyroid cancer
(PTC) is controversial. We aimed to investigate if prophylactic CLND aids risk stratification …

Opinion statement The incidence of thyroid cancer has been increasing over the past 30
years, and it is now the seventh most common cancer in women. Papillary thyroid cancer is …